Is SUVmax a useful marker for progression-free survival in patients with metastatic GEP-NET receiving <sup>177</sup>Lu-DOTATATE therapy?

F, Teker; U, Elboga

doi:10.1967/s002449912352

Public

Is SUVmax a useful marker for progression-free survival in patients with metastatic GEP-NET receiving <sup>177</sup>Lu-DOTATATE therapy?

Shared by NobleBlocks on May 1, 2021 • 12:00 AM UTC

Authors:

Teker F

Elboga U

Abstract

<h4>Objective</h4>The prognostic potential of pretreatment maximum standardized uptake volume (SUVmax) on gallium-68-DOTATATE was evaluated with positron emission tomography/computed tomography (<sup>68</sup>Ga-DOTATATE PET/CT) in 37 patients with G1/G2 gastroenteropancreatic neuroendocrine tumors (...

Discussions